CD8A and neoplasm: BRB-E administration in carcinogen-induced mice attenuates the differentiation and infiltration of Tregs to the tumor site, limiting the immunosuppressive microenvironment, and is associated with an increased presence of antitumoral CD8+ T cells and enhanced Granzyme B production.